IFNG and chronic granulomatous disease: Alternatively, IFN-γ has been shown to increase macrophage clearance of apoptotic cells in chronic granulomatous disease (CGD) [33], and is used prophylactically in CGD patients to prevent acquisition of severe infections such as Burkholderia species [34], [35].